DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Telli ML, Timms KM, Reid J, Hennessy B, Mills GB, Jensen KC. et al.
Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer.
Clin Cancer Res 2016;
22: 3764-73
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.